meitshel

ANIX - Cancer Research Company - long

Long
meitshel Updated   
NASDAQ:ANIX   Anixa Biosciences, Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

This is not a financial advice!

Rel. Vol. on 03/15/2024 at 2.56
Shs. Float of 30.38

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

This could be a slower play.

Keep an eye on 4.3 / 5.1 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 3..2

TP approx. 6.6

Most info on the chart.

Trade carefully!
Trade closed: stop reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.